Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<EvidenceVariable xmlns="http://hl7.org/fhir">
<id value="32143"/>
<meta>
<versionId value="13"/>
<lastUpdated value="2023-12-06T21:24:16.455Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"/>
</meta>
<language value="en"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: EvidenceVariable 32143</b></p><a name="32143"> </a><a name="hc32143"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 13; Last updated: 2023-12-06 21:24:16+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-variable-definition.html">VariableDefinition</a></p></div><p><b>ArtifactPublicationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}">Active</span></p><p><b>url</b>: <a href="https://fevir.net/resources/EvidenceVariable/32143">https://fevir.net/resources/EvidenceVariable/32143</a></p><p><b>identifier</b>: FEvIR Object Identifier/32143</p><p><b>name</b>: OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years</p><p><b>title</b>: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years</p><p><b>citeAs</b>: </p><div><p>OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 32143. Revised 2022-05-28. Available at: https://fevir.net/resources/EvidenceVariable/32143. Computable resource at: https://fevir.net/resources/EvidenceVariable/32143.</p>
</div><p><b>status</b>: Active</p><p><b>date</b>: 2022-05-28 12:16:43+0000</p><p><b>author</b>: Brian S. Alper: </p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years</p>
</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><p><b>actual</b>: true</p><h3>Definitions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Reference</b></td></tr><tr><td style="display: none">*</td><td><a href="Group-172480.html">OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control</a></td></tr></table><p><b>handling</b>: <span title="Codes:{https://fevir.net/sevco STATO:0000090}">dichotomous variable</span></p></div>
</text>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
<code value="active"/>
<display value="Active"/>
</coding>
</valueCodeableConcept>
</extension>
<url value="https://fevir.net/resources/EvidenceVariable/32143"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net/FOI"/>
<value value="32143"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<name
value="OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years"/>
<title
value="OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years"/>
<citeAs
value="OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 32143. Revised 2022-05-28. Available at: https://fevir.net/resources/EvidenceVariable/32143. Computable resource at: https://fevir.net/resources/EvidenceVariable/32143."/>
<status value="active"/>
<date value="2022-05-28T12:16:43.370Z"/>
<author>
<name value="Brian S. Alper"/>
</author>
<publisher value="Computable Publishing LLC"/>
<contact>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</contact>
<description
value="The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years"/>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<actual value="true"/>
<definition>
<reference>🔗
<reference value="Group/172480"/>
<type value="Group"/>
<display
value="OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control"/>
</reference>
</definition>
<handling>
<coding>
<system value="https://fevir.net/sevco"/>
<code value="STATO:0000090"/>
<display value="dichotomous variable"/>
</coding>
</handling>
</EvidenceVariable>